Literature DB >> 23547550

Diabetic ketoacidosis: evaluation and treatment.

Dyanne P Westerberg1.   

Abstract

Diabetic ketoacidosis is characterized by a serum glucose level greater than 250 mg per dL, a pH less than 7.3, a serum bicarbonate level less than 18 mEq per L, an elevated serum ketone level, and dehydration. Insulin deficiency is the main precipitating factor. Diabetic ketoacidosis can occur in persons of all ages, with 14 percent of cases occurring in persons older than 70 years, 23 percent in persons 51 to 70 years of age, 27 percent in persons 30 to 50 years of age, and 36 percent in persons younger than 30 years. The case fatality rate is 1 to 5 percent. About one-third of all cases are in persons without a history of diabetes mellitus. Common symptoms include polyuria with polydipsia (98 percent), weight loss (81 percent), fatigue (62 percent), dyspnea (57 percent), vomiting (46 percent), preceding febrile illness (40 percent), abdominal pain (32 percent), and polyphagia (23 percent). Measurement of A1C, blood urea nitrogen, creatinine, serum glucose, electrolytes, pH, and serum ketones; complete blood count; urinalysis; electrocardiography; and calculation of anion gap and osmolar gap can differentiate diabetic ketoacidosis from hyperosmolar hyperglycemic state, gastroenteritis, starvation ketosis, and other metabolic syndromes, and can assist in diagnosing comorbid conditions. Appropriate treatment includes administering intravenous fluids and insulin, and monitoring glucose and electrolyte levels. Cerebral edema is a rare but severe complication that occurs predominantly in children. Physicians should recognize the signs of diabetic ketoacidosis for prompt diagnosis, and identify early symptoms to prevent it. Patient education should include information on how to adjust insulin during times of illness and how to monitor glucose and ketone levels, as well as information on the importance of medication compliance.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23547550

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  33 in total

1.  Euglycemic diabetic ketoacidosis in type 2 diabetes treated with a sodium-glucose cotransporter-2 inhibitor.

Authors:  Mazen Jazi; George Porfiris
Journal:  Can Fam Physician       Date:  2016-09       Impact factor: 3.275

2.  [L'acidocétose euglycémique dans le diabète de type 2 traité avec un inhibiteur du cotransporteur sodium-glucose de type 2].

Authors:  Mazen Jazi; George Porfiris
Journal:  Can Fam Physician       Date:  2016-09       Impact factor: 3.275

3.  Corneal hydrops induced by diabetic ketoacidosis: A case report.

Authors:  Meiyan Feng; Chao Wang
Journal:  Exp Ther Med       Date:  2016-07-14       Impact factor: 2.447

4.  Active Subjects With Autoimmune Type 1 Diabetes Have Better Metabolic Profiles Than Sedentary Controls.

Authors:  M Adamo; R Codella; F Casiraghi; A Ferrulli; C Macrì; E Bazzigaluppi; I Terruzzi; L Inverardi; C Ricordi; L Luzi
Journal:  Cell Transplant       Date:  2016-09-20       Impact factor: 4.064

5.  Systemic alterations in the metabolome of diabetic NOD mice delineate increased oxidative stress accompanied by reduced inflammation and hypertriglyceremia.

Authors:  Johannes Fahrmann; Dmitry Grapov; Jun Yang; Bruce Hammock; Oliver Fiehn; Graeme I Bell; Manami Hara
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-04-07       Impact factor: 4.310

6. 

Authors:  Erin Gallagher; Henry Yu-Hin Siu
Journal:  Can Fam Physician       Date:  2020-06       Impact factor: 3.275

7.  Bicarbonate correction of ketoacidosis alters host-pathogen interactions and alleviates mucormycosis.

Authors:  Teclegiorgis Gebremariam; Lin Lin; Mingfu Liu; Dimitrios P Kontoyiannis; Samuel French; John E Edwards; Scott G Filler; Ashraf S Ibrahim
Journal:  J Clin Invest       Date:  2016-05-09       Impact factor: 14.808

8.  Diabetic ketoacidosis as first presentation of type 1 diabetes mellitus in a young child: Important differential diagnosis for respiratory distress.

Authors:  Erin Gallagher; Henry Yu-Hin Siu
Journal:  Can Fam Physician       Date:  2020-06       Impact factor: 3.275

9.  Understanding antagonism and synergism: A qualitative assessment of weight management in youth with Type 1 diabetes mellitus.

Authors:  Anna R Kahkoska; Madison E Watts; Kimberly A Driscoll; Franziska K Bishop; Paul Mihas; Joan Thomas; Jennifer R Law; Nina Jain; Elizabeth J Mayer-Davis
Journal:  Obes Med       Date:  2018-02-22

10.  Skeletal muscle PGC-1α modulates systemic ketone body homeostasis and ameliorates diabetic hyperketonemia in mice.

Authors:  Kristoffer Svensson; Verena Albert; Bettina Cardel; Silvia Salatino; Christoph Handschin
Journal:  FASEB J       Date:  2016-02-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.